29/07/2026
#๐๐ฑ๐๐๐๐ถ๐ผ๐๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ๐ ๐ฎ๐ ๐๐๐๐ฆ ๐ฎ๐ฌ๐ฎ๐ฒ | ๐ฅ๐ถ๐ผ ๐ฑ๐ฒ ๐๐ฎ๐ป๐ฒ๐ถ๐ฟ๐ผ, ๐๐ฟ๐ฎ๐๐ถ๐น
We are proud to share that ๐๐ฑ๐๐ ๐๐ถ๐ผ๐๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ๐ ๐ฃ๐๐. ๐๐๐ฑ. is participating as a ๐๐ถ๐๐ถ๐๐ผ๐ฟ at the ๐ฎ๐ฒ๐๐ต ๐๐ป๐๐ฒ๐ฟ๐ป๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐๐๐๐ฆ ๐๐ผ๐ป๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ (๐๐๐๐ฆ ๐ฎ๐ฌ๐ฎ๐ฒ) in Rio de Janeiro, Brazil.
AIDS 2026 is the worldโs largest and most influential conference on HIV and AIDS, bringing together scientists, clinicians, policymakers, global health organizations, industry leaders, community advocates, and funding partners to accelerate progress toward ending HIV as a public health threat. This yearโs conference is being held under the inspiring theme โ๐ฅ๐ฒ๐๐ต๐ถ๐ป๐ธ. ๐ฅ๐ฒ๐ฏ๐๐ถ๐น๐ฑ. ๐ฅ๐ถ๐๐ฒ.โ, emphasizing innovation, resilient health systems, sustainable partnerships, and renewed global commitment to the fight against HIV/AIDS.
As a visitor, our objective is to engage with the global HIV community, gain insights into the latest scientific and technological advancements, and strengthen collaborations with international partners committed to expanding access to quality HIV diagnostics.
At Advy Biosciences, we remain dedicated to supporting global public health through reliable, high-quality in vitro diagnostic solutions. We believe that innovation, collaboration, and equitable access to diagnostics are essential to achieving the global goal of ending HIV/AIDS.
We look forward to meaningful discussions and partnerships with stakeholders from across the global health ecosystem, including international agencies, procurement organizations, implementing partners, and healthcare leaders working together to improve HIV prevention, diagnosis, and care.
Together, letโs ๐ฅ๐ฒ๐๐ต๐ถ๐ป๐ธ. ๐ฅ๐ฒ๐ฏ๐๐ถ๐น๐ฑ. ๐ฅ๐ถ๐๐ฒ. for a future free from HIV/AIDS.